Skip to main content
Signal8

Amplia Therapeutics Limited (INNMF)

Established in 2000 and headquartered in Melbourne, Australia, Amplia Therapeutics Limited is a pharmaceutical firm dedicated to the discovery and development of focal adhesion kinase (FAK) inhibitors. The company's therapeutic endeavors are concentrated on oncology (cancer) and chronic fibrotic diseases. Its drug development pipeline includes AMP945, a FAK inhibitor that has successfully completed Phase I clinical trials and is being explored for its efficacy in treating pancreatic cancer, idiopathic pulmonary fibrosis, and a broader spectrum of cancerous and fibrotic conditions. Another compound, AMP886, is also under development for potential applications in cancer and fibrotic disorders. Amplia Therapeutics maintains a strategic collaboration with the Garvan Institute of Medical Research in Sydney, and the company adopted its current name in September 2018, having previously operated as Innate Immunotherapeutics Limited.

Sector: Biotechnology

Industry: Biotechnology

Amplia Therapeutics Limited logo

Amplia Therapeutics Limited

OTC:INNMFHealthcare
-15.56%$0.0535
CLOSED
Mkt Cap$27.46M
EV$8.87M
Float479.04M
O/S513.31M
VOL475 sh
$ Vol$25
RVOL0.04×
Inst Own-
SI<0.1%
Net Cash/Sh+$0.04
Dilution
Amplia Therapeutics Limited logoOTC:INNMFClosed$0.0535-15.56%
Financials Summary
Revenue$0
Net Income-$5.22M
Total Assets$28.05M
Free Cash Flow-$5.93M
Debt & Equity
Debt 1%
Equity 99%
Total Debt$231K
Total Equity$26.72M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:10Reverse split
    May 3, 201810 shares → 1
Balance Sheet Details
Assets$28.05M
Liabilities$1.33M
Accounts Receivable$3.23M
Accounts Payable$948K
Inventory$0
PP&E (Net)$240K
Goodwill$0
Intangible Assets$5.37M
Income Statement
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Revenue$0$2.56M$3.01M$804K$1.34M$1.04M$23K$34K$392K$1.21M$1.53M$20K$0$0$0$0$0
YoY Growth--15.0%274.3%-40.0%29.3%4380.4%-32.2%-91.3%-67.7%-20.6%7367.5%------
Cost of Revenue$62K$142K$299K$50K$2K$454$541$1K$14K$25K$384K$161K$113K$160K$884K$899K$950K
Gross Profit-$62K$2.41M$2.71M$754K$1.34M$1.04M$23K$33K$378K$1.19M$1.15M-$140K-$113K-$160K-$884K-$899K-$950K
Gross Margin-94.4%90.1%93.8%99.8%100.0%97.7%96.8%96.5%97.9%74.9%-685.2%-----
Research and Development$6.15M$5.09M$3.92M$3.17M$2.55M$1.49M$724K$458K$2.18M$4.08M$3.21M$1.38M$438K$523K$871K$653K$728K
Selling, General, and Administrative$2.45M$1.86M$1.82M$1.83M$1.25M$1.12M$802K$747K$965K$1.62M$997K$1.08M$1.18M$635K$581K$294K$821K
Other$266K-$129K-$40K$0$0$0$0$34K$434K$1.24M$1.55M$20K$19K$0$0$0$0
Total Operating Expenses$8.86M$6.82M$5.7M$5M$3.8M$2.62M$1.53M$1.3M$3.25M$6.04M$4.56M$3.67M$2.76M$1.74M$1.45M$947K$1.55M
Operating Income (EBIT)-$8.92M-$4.4M-$2.99M-$4.18M-$2.46M-$1.54M-$1.53M-$1.3M-$3.26M-$6.06M-$4.94M-$3.65M-$2.76M-$2.05M-$2.34M-$1.85M-$2.5M
Operating Margin--172.2%-99.4%-520.3%-183.7%-148.8%-6600.4%-3816.5%-831.6%-498.8%-323.0%-17810.7%-----
Interest Expense$12K$0$53K$36K$777$0$0$0$0$0$8$8$333K$0$302K$265K$112K
Interest Income$473K$149K$98K$66K$416$874$3K$14K$18K$41K$50K$109K$39K$387K$30K$18K$9K
Other Income (Expense)$470K-$38K-$3.05M-$36K-$777$1.08M$4K$4K$357K$1.28M$50K$109K-$294K-$242K$138K$195K-$248K
Income Before Tax (EBT)-$8.45M-$4.44M-$6.04M-$4.22M-$2.46M-$1.54M-$1.52M-$1.3M-$2.9M-$6M-$4.87M-$3.54M-$3.04M-$2.29M-$2.2M-$1.65M-$2.75M
Income Tax Expense-$3.23M$0-$3M$0$0$0-$23K-$34K-$1-$1.21M-$1.53M-$109K$352K$0$0$0$0
Net Income-$5.22M-$4.44M-$3.04M-$4.22M-$2.46M-$1.54M-$1.5M-$1.26M-$2.9M-$4.78M-$3.34M-$3.54M-$3.04M-$2.29M-$2.2M-$1.65M-$2.75M
Net Income Margin--173.7%-101.1%-524.8%-183.7%-148.8%-6484.6%-3704.8%-740.6%-393.5%-218.4%-17278.7%-----
Supplementary Data
EPS-0.02-0.02-0.02-0.03-0.03-0.02-0.04-0.04-0.17-0.30-0.24-0.27-0.34-0.20-0.15-0.12-0.19
Diluted EPS-0.02-0.02-0.02-0.03-0.03-0.02-0.04-0.04-0.17-0.30-0.24-0.27-0.34-0.20-0.15-0.12-0.19
Weighted Average OS469.65M307.10M194.01M193.98M145.55M95.70M52.96M43.44M25.36M23.92M20.62M19.08M13.04M17.32M21.21M21.21M21.21M
EBITDA-$8.86M-$4.54M-$3.03M-$4.91M-$2.46M-$1.58M-$1.52M-$1.3M-$2.91M-$4.8M-$3.01M-$2.49M-$1.76M-$1M-$1.01M-$487K-$1.68M
EBITDA Margin--177.5%-100.7%-610.7%-183.6%-152.6%-6582.2%-3801.7%-741.8%-394.9%-196.6%-12169.0%-----
Balance Sheet
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Assets
Current Assets
Cash and Cash Equivalents$18.86M$7.34M$2.29M$6.25M$9.87M$1.25M$749K$838K$1.51M$3.89M$2.16M$2.76M$5.37M$5.65M$789K$1.41M$751K
Short-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Cash and Short-Term Investments$18.86M$7.34M$2.29M$6.25M$9.87M$1.25M$749K$838K$1.51M$3.89M$2.16M$2.76M$5.37M$5.65M$789K$1.41M$751K
Accounts Receivable$3.23M$2.55M$2.15M$776K$1.25M$676K$23K$0$165K$89K$52K$18K$15K$22K$40K$180K$19K
Inventory$0$0$0$0$0$0$0$0$0$0$0$325K-$111$0$0$0$0
Other Current Assets$162K$125K$78K$45K$32K$28K$7K$0$115K$977K$994K$20K$5K$676$0$32K$11K
Total Current Assets$22.37M$10.09M$4.56M$7.1M$11.17M$1.98M$796K$846K$1.79M$4.98M$3.3M$3.12M$5.39M$5.67M$829K$1.62M$781K
Long-Term Assets
Property, Plant & Equipment Net$240K$12K$68K$125K$9K$4K$539$1K$0$110K$102K$108K$109K$113K$135K$152K$199K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Intangible Assets$5.37M$5.36M$5.36M$5.36M$5.36M$5.36M$5.36M$5.36M$0$0$0$361K$1.38M$1.94M$2.92M$3.54M$4.56M
Long-Term Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$4K
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$72K$36K$36K$36K$0$0$0-$5.36M$0-$110K-$102K$304$253$0$0$0$1
Total Long-Term Assets$5.69M$5.41M$5.47M$5.52M$5.37M$5.37M$5.36M$5.36M$0$110K$102K$469K$1.49M$2.05M$3.05M$3.69M$4.76M
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$28.05M$15.5M$10.03M$12.62M$16.54M$7.35M$6.16M$6.21M$1.79M$5.09M$3.4M$3.59M$6.88M$7.72M$3.88M$5.31M$5.54M
Liabilities
Current Liabilities
Accounts Payable$948K$1.06M$1.08M$235K$249K$282K$320K$266K$770$60K$50K$51K$61K$129K$226K$31K$25K
Short-Term Debt$60K$0$1.01M$1.42M$0$0$0$7K$0$0$0$0$0$0$1.25M$0$0
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$0$0$0$0$0$0$0-$7K$0-$7K-$7K$0$0-$2.22M$0$0$0
Other Current Liabilities$122K$47K$154K$150K$109K-$47K$7K$0$7K$7K$7K$255K$212K$2.12M$82K$84K$79K
Total Current Liabilities$1.13M$1.28M$2.3M$1.86M$358K$364K$345K$356K$189K$613K$697K$306K$273K$129K$1.58M$122K$106K
Long-Term Liabilities
Long-Term Debt$0$0$0$0$1.42M$0$0$0$0$0$0$0$0$0$144K$1.08M$1.4M
Long-Term Unearned Revenue$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$31K$16K$6K$2K$4K$0$0$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$202K$16K$16K$66K$1.42M$0$0$0$0$0$0$0$0$0$144K$1.08M$1.4M
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities$1.33M$1.29M$2.32M$1.92M$1.78M$364K$345K$356K$189K$613K$697K$306K$273K$129K$1.72M$1.2M$1.51M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$237K$0$355K$0$0$0$0$0$0
Common Stock$130.94M$113.1M$102.38M$102.38M$102.37M$92.26M$89.8M$88.47M$83.12M$83.12M$77.18M$74.47M$74.47M$78.56M$65.56M$61.13M$62.37M
Retained Earnings-$103.46M-$98.33M-$93.93M-$91.03M-$86.9M-$84.6M-$83.06M-$81.7M-$81.29M-$78.9M-$74.12M-$70.78M-$67.24M-$71.32M-$63.92M-$57.75M-$59.91M
Comprehensive Income & Other-$764K-$558K-$741K-$655K-$704K-$680K-$927K-$921K-$237K$263K-$355K-$404K-$628K$345K$524K$732K$1.58M
Other Stockholders' Equity-$764K-$558K-$741K-$655K-$704K-$680K-$927K-$921K-$237K$263K-$355K-$403K-$627K$345K$524K$732K$1.58M
Total Equity$26.72M$14.21M$7.71M$10.7M$14.76M$6.99M$5.81M$5.85M$1.6M$4.48M$2.7M$3.29M$6.6M$7.59M$2.16M$4.1M$4.04M
Minority Interest$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Liabilities and Equity$28.05M$15.5M$10.03M$12.62M$16.54M$7.35M$6.16M$6.21M$1.79M$5.09M$3.4M$3.59M$6.88M$7.72M$3.88M$5.31M$5.54M
Supplementary Data
Total Debt$231K$9K$1.07M$1.53M$1.42M$0$0$7K$0$7K$7K$0$0$2.07M$1.4M$1.08M$1.4M
Net Debt-$18.62M-$7.33M-$1.22M-$4.72M-$8.45M-$1.25M-$749K-$831K-$1.51M-$3.89M-$2.16M-$2.76M-$5.37M-$3.58M$610K-$327K$649K
Cash Flow Statement
PeriodFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2026-03-312025-03-312024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-312014-03-312013-03-312012-03-312011-03-312010-03-31
Operating Activities
Net Income-$5.22M-$2.77M-$3.04M-$4.22M-$2.46M-$1.54M-$1.5M-$1.26M-$2.9M-$4.78M-$3.34M-$3.54M-$3.04M-$2.29M-$2.2M-$1.65M-$2.75M
Depreciation & Amortization$62K$52K$59K$50K$2K$454$541$1K$14K$25K$384K$1.05M$987K$898K$884K$899K$950K
Deferred Income Tax$0$0$0$212K-$601K-$909K-$189K-$438K-$859K-$676K$621K$229K-$417K-$161K$0$0$0
Stock-Based Compensation$0$53K$58K$141K$41K$239K$137K$165K$50K$628K$154K$120K$421K$144K$0$0$0
Changes in Working Capital:
  Accounts Receivable-$746K-$451K-$1.38M$460K-$558K-$688K-$40K$273K$809K$48K-$775K-$349K-$3K$17K$32K-$39K$6K
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
  Accounts Payable-$192K$0$0-$7K$3K$19K-$11K$167K-$425K-$83K$391K$0$0$0$174K$12K$75K
  Other Working Capital$0$0$0$0$0$0$0-$167K$425K$83K-$391K$0$0$0-$7K$5K$40K
Total Working Capital Change-$938K-$451K-$1.38M$452K-$555K-$669K-$51K$273K$809K$48K-$775K-$349K-$3K$17K$199K-$22K$121K
Other Non-Cash Items$181K-$1.53M$843K-$212K$601K$909K$191K$595K$492K-$83K$391K-$196K$966K$206K$256K-$309K$299K
Net Cash from Operating-$5.91M-$4.65M-$3.46M-$3.57M-$2.97M-$1.97M-$1.41M-$667K-$2.4M-$4.16M-$3.19M-$2.69M-$1.08M-$1.19M-$859K-$1.08M-$1.38M
Investing Activities
Capital Expenditures-$23K-$1K-$2K-$12K-$10K-$4K$0-$2K-$3K-$31K-$26K-$17K-$676$0-$5K-$4K-$8K
Acquisitions$0$0$0$0$0$0$0$0$4K$0$0$0$0$0$3K$4K$3K
Purchases of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Sales of Investments$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$4K$0
Other Investing Activities-$43K$0$0-$28K-$8K$0$0$0$0-$356-$39-$21$106$5K$0$0$0
Net Cash from Investing-$65K-$1K-$2K-$39K-$18K-$4K$0-$2K$1K-$31K-$26K-$17K-$676$5K-$1K$3K-$5K
Financing Activities
Debt Repaid-$1.05M$428K$44K-$1.42M--------$360K----$194K
Common Stock Issuance$17.62M$11.68M$163$14K$10.99M$2.75M$1.32M$0$0$5.89M$2.71M$0$6.79M$0$159K$1.81M$935K
Common Stock Repurchases$0-$899K$0$0-$799K-$270K-$129K-$8K-$9K-$136K-$44K$0-$774K$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$60K-$55K-$95K-$28K$10.2M$2.48M$0-$8K-$9K$0$0$0$0$483K$0$0$0
Net Cash from Financing$17.56M$9.68M-$522K-$57K$11.61M$2.48M$1.32M-$8K-$9K$5.89M$2.71M-$1K$6.37M$483K$159K$1.81M$1.13M
Forex Effect$619K$31K$21K$54K-$126-$953-$2K$10K$17K$38K-$96K$103K-$2K-$8K$0$0$0
Net Change in Cash$12.2M$5.05M-$3.97M-$3.62M$8.62M$500K-$90K-$668K-$2.39M$1.73M-$600K-$2.6M$5.29M-$706K$0$0$0
Supplementary Data
Operating Cash Flow-$5.91M-$4.65M-$3.46M-$3.57M-$2.97M-$1.97M-$1.41M-$667K-$2.4M-$4.16M-$3.19M-$2.69M-$1.08M-$1.19M-$859K-$1.08M-$1.38M
Capital Expenditure-$23K-$1K-$2K-$12K-$10K-$4K$0-$2K-$3K-$31K-$26K-$17K-$676$0-$5K-$4K-$8K
Free Cash Flow-$5.93M-$4.65M-$3.47M-$3.59M-$2.98M-$1.97M-$1.41M-$669K-$2.4M-$4.19M-$3.21M-$2.7M-$1.08M-$1.19M-$864K-$1.09M-$1.38M
Cash at Beginning$6.66M$2.29M$6.25M$9.87M$1.25M$749K$838K$1.51M$3.89M$2.16M$2.76M$5.37M$79K$785K$1.41M$751K$0
Cash at End$18.86M$7.34M$2.29M$6.25M$9.87M$1.25M$749K$838K$1.51M$3.89M$2.16M$2.76M$5.37M$79K$789K$1.41M$751K